Stock listing
ARCT Stock Price, News, Filings & Events — Arcturus Therapeutics Holdings Inc.
Selected listing: ARCT · NASDAQ · USD · US
ARCT:NASDAQ is the primary listing for Arcturus Therapeutics Holdings Inc., a company dedicated to developing innovative RNA medicines. With a market capitalization of approximately $171.96 million, Arcturus utilizes its proprietary technology platform to tackle unmet medical needs in the healthcare sector. Recent news and filings may provide insights into the company's ongoing projects and strategic direction, reflecting its commitment to advancing RNA-based therapies.
- Ticker
- ARCT:NASDAQ
- Asset type
- Stock
- Market cap
- $172.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Arcturus Therapeutics Holdings Inc. ARCT:NASDAQ stock context
ARCT:NASDAQ is the primary listing for Arcturus Therapeutics Holdings Inc., a company dedicated to developing innovative RNA medicines. With a market capitalization of approximately $171.96 million, Arcturus utilizes its proprietary technology platform to tackle unmet medical needs in the healthcare sector. Recent news and filings may provide insights into the company's ongoing projects and strategic direction, reflecting its commitment to advancing RNA-based therapies.
Research Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc. investor report
Review AI stock analysis and investor report context for ARCT:NASDAQ.
Arcturus Therapeutics Holdings Inc. company profile
View the public company page for Arcturus Therapeutics Holdings Inc. on 6ix.
Arcturus Therapeutics Holdings Inc. news
Read company news and market updates connected to Arcturus Therapeutics Holdings Inc..
Arcturus Therapeutics Holdings Inc. investor events
Find investor webinars, events, and replay context for Arcturus Therapeutics Holdings Inc..